91
Views
36
CrossRef citations to date
0
Altmetric
Original Research

Blood MCP-1 levels are increased in chronic obstructive pulmonary disease patients with prevalent emphysema

, , , , , & show all
Pages 1691-1700 | Published online: 24 May 2018

References

  • VestboJHurdSSAgustiAGGlobal strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
  • ReubenDBChehAIHarrisTBPeripheral blood markers of inflammation predict mortality and functional decline in high-functioning community-dwelling older personsJ Am Geriatr Soc200250463864411982663
  • KuschnerWGD’AlessandroAWongHBlancPDDose-dependent cigarette smoking-related inflammatory responses in healthy adultsEur Respir J1996910198919948902455
  • CapelliADi StefanoAGnemmiIIncreased MCP-1 and MIP-1beta in bronchoalveolar lavage fluid of chronic bronchitisEur Respir J199914116016510489845
  • LiuSFWangCCFangWFChenYCLinMCMCP1-2518 polymorphism and chronic obstructive pulmonary disease in Taiwanese menExp Lung Res201036527728320497022
  • LordPCWilmothLMMizelSBMcCallCEExpression of interleukin-1 alpha and beta genes by human blood polymorphonuclear leukocytesJ Clin Invest1991874131213212010544
  • RosenwasserLJBiologic activities of IL-1 and its role in human diseaseJ Allergy Clin Immunol199810233443509768571
  • FerhaniNLetuveSKozhichAExpression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2010181991792720133931
  • SinghBAroraSKhannaVAssociation of severity of COPD with IgE and interleukin-1 betaMonaldi Arch Chest Dis2010732868720949775
  • TanniSEPelegrinoNRAngeleliAYCorreaCGodoyISmoking status and tumor necrosis factor-alpha mediated systemic inflammation in COPD patientsJ Inflamm (Lond)201072920534161
  • WedzichaJASeemungalTAMacCallumPKAcute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levelsThromb Haemost200084221021510959691
  • CosioMGSaettaMAgustiAImmunologic aspects of chronic obstructive pulmonary diseaseN Engl J Med2009360232445245419494220
  • SeemungalTHarper-OwenRBhowmikARespiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200116491618162311719299
  • VanfleterenLESpruitMAGroenenMClusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2013187772873523392440
  • BarnesPJCytokine-directed therapies for the treatment of chronic airway diseasesCytokine Growth Factor Rev200314651152214563353
  • LewisMIApoptosis as a potential mechanism of muscle cachexia in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2002166443443612186814
  • PaoneGLeoneVContiVBlood and sputum biomarkers in COPD and asthma: a reviewEur Rev Med Pharmacol Sci201620469870826957273
  • TemannUAPrasadBGallupMWA novel role for murine IL-4 in vivo: induction of MUC5AC gene expression and mucin hypersecretionAm J Respir Cell Mol Biol19971644714789115759
  • DabbaghKTakeyamaKLeeHMUekiIFLausierJANadelJAIL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivoJ Immunol1999162106233623710229869
  • Solleiro-VillavicencioHQuintana-CarrilloRFalfán-ValenciaRVargas-RojasMIChronic obstructive pulmonary disease induced by exposure to biomass smoke is associated with a Th2 cytokine production profileClin Immunol2015161215015526220216
  • SchoenbornJRWilsonCBRegulation of interferon-gamma during innate and adaptive immune responsesAdv Immunol2007964110117981204
  • AlmansaRSanchez-GarciaMHerreroAHost response cytokine signatures in viral and nonviral acute exacerbations of chronic obstructive pulmonary diseaseJ Interferon Cytokine Res201131540941321235417
  • HirstSJBarnesPJTwortCHQuantifying proliferation of cultured human and rabbit airway smooth muscle cells in response to serum and platelet derived growth factorAm J Respir Cell Mol Biol1992765745811449805
  • VignolaAMChanezPChiapparaGTransforming growth factor-b expression in mucosal biopsies in asthma and chronic bronchitisAm J Respir Crit Care Med19971562 Pt 15915999279245
  • SadowskaAMLuytenCVintsAMVerbraeckenJVan RanstDDe BackerWASystemic antioxidant defences during acute exacerbation of chronic obstructive pulmonary diseaseRespirology200611674174717052302
  • MusiekESMorrowJDF2-isoprostanes as markers of oxidant stress: an overviewCurr Protoc Toxicol2005 Chapter 17:Unit 17.5
  • RokachJKhanapureSPHwangSWAdiyamanMLawsonJAFitzGeraldGANomenclature of isoprostanes: a proposalProstaglandins19975468538739533181
  • BanerjeeMKangKHMorrowJDRobertsLJNewmanJHEffects of a novel prostaglandin, 8-epi PGF2 alpha, in rabbit lung in situAm J Physiol19922633 Pt 2H660H6631415588
  • KawikovaIBarnesPJTakasakiTTadjkarimiSYacoubMHBelvisMG8-epi prostaglandin F2a, a novel noncyclooxygenase derived prostaglandin, constricts airways in vitroAm J Respir Crit Care Med19961535905968564103
  • PistolesiMCamiciottoliGPaolettiMIdentification of a predominant COPD phenotype in clinical practiceRespir Med2008102336737618248806
  • CamiciottoliGBigazziFPaolettiMCestelliLLavoriniFPistolesiMPulmonary function and sputum characteristics predict computed tomography phenotype and severity of COPDEur Respir J201342362663523258785
  • Di StefanoACaramoriGGnemmiIAssociation of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPDThorax2009641196897519703829
  • QuanjerPHTammelingGJCotesJEPedersenOFPeslinRYernaultJCLung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory SocietyEur Respir J Suppl1993165408499054
  • FitzGeraldSPLamontJVMcConnellRIBenchikh elODevelopment of a high-throughput automated analyzer using biochip array technologyClin Chem20055171165117615890889
  • SignoriniCComportiMGiorgiGIon trap tandem mass spectrometric determination of F2-isoprostanesJ Mass Spectrom200338101067107414595856
  • SignoriniCCiccoliLLeonciniSFree iron, total F-isoprostanes and total F-neuroprostanes in a model of neonatal hypoxic-ischemic encephalopathy: neuroprotective effect of melatoninJ Pineal Res200946214815419141088
  • De FeliceCCiccoliLLeonciniSSystemic oxidative stress in classic Rett syndromeFree Radic Biol Med200947444044819464363
  • SignoriniCPerroneSSgherriCPlasma esterified F2-isoprostanes and oxidative stress in newborns: role of nonprotein-bound ironPediatr Res200863328729118287967
  • SofflerCCampbellVLHasselDMMeasurement of urinary F2-isoprostanes as markers of in vivo lipid peroxidation: a comparison of enzyme immunoassays with gas chromatography-mass spectrometry in domestic animal speciesJ Vet Diagn Invest201022220020920224077
  • RetamalesIElliottWMMeshiBAmplification of inflammation in emphysema and its association with latent adenoviral infectionAm J Respir Crit Care Med2001164346947311500352
  • Mateu-JiménezMSánchez-FontARodríguez-FusterARedox imbalance in lung cancer of patients with underlying chronic respiratory conditionsMol Med Epub201617
  • YoungRPHopkinsRBlackPNFunctional variants of antioxidant genes in smokers with COPD and in those with normal lung functionThorax200661539439916467073
  • MontuschiPCollinsJVCiabattoniGExhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokersAm J Respir Crit Care Med20001623 Pt 11175117710988150
  • RolinSMasereelBDognéJMProstanoids as pharmacological targets in COPD and asthmaEur J Pharmacol20065331–38910016458293
  • SantosMCOliveiraALViegas-CrespoAMSystemic markers of the redox balance in chronic obstructive pulmonary diseaseBiomarkers20049646146915849066
  • KluchováZPetrásováDJoppaPDorkováZTkácováRThe association between oxidative stress and obstructive lung impairment in patients with COPDPhysiol Res2007561515616497100
  • CockayneDAChengDTWaschkiBSystemic biomarkers of neutrophilic inflammation, tissue injury and repair in COPD patients with differing levels of disease severityPLoS One201276e3862922701684
  • de-TorresJPBlancoDAlcaideABSmokers with CT detected emphysema and no airway obstruction have decreased plasma levels of EGF, IL-15, IL-8 and IL-1raPLoS One201384e6026023577098
  • AgustiASinDDBiomarkers in COPDClin Chest Med201435113114124507841
  • BradfordEJacobsonSVarastehJThe value of blood cytokines and chemokines in assessing COPDRespir Res201718118029065892
  • D’ArmientoJMScharfSMRothMDEosinophil and T cell markers predict functional decline in COPD patientsRespir Res20091011319925666
  • ZhangLChengZLiuWWuKExpression of interleukin (IL)-10, IL-17A and IL-22 in serum and sputum of stable chronic obstructive pulmonary disease patientsCOPD201310445946523537276
  • Farid HosseiniRJabbari AzadFYousefzadehHSerum levels of vascular endothelial growth factor in chronic obstructive pulmonary diseaseMed J Islam Repub Iran20142885 eCollection 201425664286
  • BoeckLMandalJCostaLRothMTammMStolzDLongitudinal measurement of serum vascular endothelial growth factor in patients with chronic obstructive pulmonary diseaseRespiration20159029710426066063
  • NikotaJKShenPMorissetteMCCigarette smoke primes the pulmonary environment to IL-1α/CXCR-2-dependent nontypeable Haemophilus influenzae-exacerbated neutrophilia in miceJ Immunol201419363134314525092891
  • BotelhoFMNikotaJKBauerCMCigarette smoke-induced accumulation of lung dendritic cells is interleukin-1α-dependent in miceRespir Res2012138122992200
  • OseiETNoordhoekJAHackettTLInterleukin-1α drives the dysfunctional cross-talk of the airway epithelium and lung fibroblasts in COPDEur Respir J201648235936927418555
  • SinghBAroraSKhannaVAssociation of severity of COPD with IgE and interleukin-1 betaMonaldi Arch Chest Dis2010732868720949775
  • FuJJMcDonaldVMBainesKJGibsonPGAirway IL-1β and systemic inflammation as predictors of future exacerbation risk in asthma and COPDChest2015148361862925950204
  • Di StefanoACaramoriGBarczykAInnate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPDThorax201469651652424430176